The Duke Clinical & Translational Science Institute (CTSI) Translational Health Research (TransPop) is a highly productive team of clinical research cooordinators, project managers, data techhnicians and regulatory, community engagement and adminisstrative staff in Kannpapolis. The team supports numerous studies, including the 12,400-participant MURDOCK Study community engagement registry and biorepository.
The team continually increases knowledge through clinical research training, conferences and presentations of MURDOCK Study recruitment strategies. Their goal is to enable research opportunities that will lead to improvement in the health and well-being of the public.
CTSI TransPop offers collaborators:
MURDOCK Study Innovation
Today, more than 12,400 participants are being followed longitudinally for health outocmes, and their data and biospecimens are available to researchers through a simple process. The diverse cohorts and in-person follow-up visits of MURDOCK Study participants can be leverage by investigators to further understand heart, lung, blood, and sleep disease and disorders. TransPop expertise in collecting EHR data and belief in collaborative team-based science allows us to support research across the translational spectrum.
MURDOCK Study nestsed cohorts are valuable in studies such as:
TransPop’s newest study, Project Baseline, was launched in 2017 as a collaboration between Verily, Duke University School of Medicine, Stanford Medicine, and Google. The Project Baseline study is an observational study that will collect, organize, and analyze broad health data from approximately 10,000 participants over the course of at least four years. The study is designed to develop a well-defined reference, or “baseline,” of good health, as well as a rich data platform that may be used to better understand the transition from health to disease.
Participants will join together with a team of experts from across academia, medicine, science, technology, engineering, and design to better understand how health can change over time. Participants will be asked to visit a study site up to four times yearly, test new technologies and wearable devices daily, and participate in interactive surveys and diaries by using a smartphone, computer, or call center. Data collected will include clinical, imaging, self-reported, physical, environmental, behavioral, sensor, molecular, genetic, and other health-related measurements. Biospecimens collected will include blood and saliva, among others. Learn more.
L. Kristin Newby, MD, MHS
Duke CTSI Translational Population Health Research
The MURDOCK Study
Duke University School of Medicine
Professor of Medicine
Duke Cardiac Care Unit